ラパチニブの世界市場 2020年

• 英文タイトル：Global Lapatinib Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115770 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、ラパチニブの世界市場を調査対象にし、ラパチニブの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（250 mg錠、タイプII）、用途別分析（病院、ドラッグストア）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Novartis ・企業別売上、市場シェア ・ラパチニブの地域別市場分析 ・ラパチニブの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ラパチニブのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ラパチニブのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ラパチニブの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ラパチニブの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ラパチニブの種類別市場規模2015-2020：250 mg錠、タイプII ・ラパチニブの用途別市場規模2015-2020：病院、ドラッグストア ・ラパチニブの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Lapatinib market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Lapatinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Lapatinib market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Lapatinib market has been segmented into:
250 mg Tablets
Type II

By Application, Lapatinib has been segmented into:
Hospital
Drug store

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lapatinib market presented in the report. This section sheds light on the sales growth of different regional and country-level Lapatinib markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lapatinib market.

The report offers in-depth assessment of the growth and other aspects of the Lapatinib market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Lapatinib Market Share Analysis
Lapatinib competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lapatinib sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lapatinib sales, revenue and market share for each player covered in this report.

The major players covered in Lapatinib are:
Novartis

レポート目次

---

1 Lapatinib Market Overview
1.1 Product Overview and Scope of Lapatinib
1.2 Classification of Lapatinib by Type
1.2.1 Global Lapatinib Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Lapatinib Revenue Market Share by Type in 2019
1.2.3 250 mg Tablets
1.2.4 Type II
1.3 Global Lapatinib Market by Application
1.3.1 Overview: Global Lapatinib Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Lapatinib Market by Regions
1.4.1 Global Lapatinib Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Lapatinib (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Lapatinib Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Lapatinib Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lapatinib Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Lapatinib Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lapatinib Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Lapatinib Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Lapatinib Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Lapatinib Players Market Share
3.2.2 Top 10 Lapatinib Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Lapatinib Revenue and Market Share by Regions
4.2 North America Lapatinib Revenue and Growth Rate (2015-2020)
4.3 Europe Lapatinib Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Lapatinib Revenue and Growth Rate (2015-2020)
4.5 South America Lapatinib Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Lapatinib Revenue and Growth Rate (2015-2020)
5 North America Lapatinib Revenue by Countries
5.1 North America Lapatinib Revenue by Countries (2015-2020)
5.2 USA Lapatinib Revenue and Growth Rate (2015-2020)
5.3 Canada Lapatinib Revenue and Growth Rate (2015-2020)
5.4 Mexico Lapatinib Revenue and Growth Rate (2015-2020)
6 Europe Lapatinib Revenue by Countries
6.1 Europe Lapatinib Revenue by Countries (2015-2020)
6.2 Germany Lapatinib Revenue and Growth Rate (2015-2020)
6.3 UK Lapatinib Revenue and Growth Rate (2015-2020)
6.4 France Lapatinib Revenue and Growth Rate (2015-2020)
6.5 Russia Lapatinib Revenue and Growth Rate (2015-2020)
6.6 Italy Lapatinib Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Lapatinib Revenue by Countries
7.1 Asia-Pacific Lapatinib Revenue by Countries (2015-2020)
7.2 China Lapatinib Revenue and Growth Rate (2015-2020)
7.3 Japan Lapatinib Revenue and Growth Rate (2015-2020)
7.4 Korea Lapatinib Revenue and Growth Rate (2015-2020)
7.5 India Lapatinib Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Lapatinib Revenue and Growth Rate (2015-2020)
8 South America Lapatinib Revenue by Countries
8.1 South America Lapatinib Revenue by Countries (2015-2020)
8.2 Brazil Lapatinib Revenue and Growth Rate (2015-2020)
8.3 Argentina Lapatinib Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Lapatinib by Countries
9.1 Middle East & Africa Lapatinib Revenue by Countries (2015-2020)
9.2 Saudi Arabia Lapatinib Revenue and Growth Rate (2015-2020)
9.3 UAE Lapatinib Revenue and Growth Rate (2015-2020)
9.4 Egypt Lapatinib Revenue and Growth Rate (2015-2020)
9.5 South Africa Lapatinib Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Lapatinib Revenue and Market Share by Type (2015-2020)
10.2 Global Lapatinib Market Forecast by Type (2019-2024)
10.3 250 mg Tablets Revenue Growth Rate (2015-2025)
10.4 Type II Revenue Growth Rate (2015-2025)
11 Global Lapatinib Market Segment by Application
11.1 Global Lapatinib Revenue Market Share by Application (2015-2020)
11.2 Lapatinib Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drug store Revenue Growth (2015-2020)
12 Global Lapatinib Market Size Forecast (2021-2025)
12.1 Global Lapatinib Market Size Forecast (2021-2025)
12.2 Global Lapatinib Market Forecast by Regions (2021-2025)
12.3 North America Lapatinib Revenue Market Forecast (2021-2025)
12.4 Europe Lapatinib Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Lapatinib Revenue Market Forecast (2021-2025)
12.6 South America Lapatinib Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Lapatinib Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Lapatinib Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lapatinib by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lapatinib Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Lapatinib Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Lapatinib Major Business
Table 7. Novartis Lapatinib Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Lapatinib Product and Solutions
Table 10. Novartis Lapatinib Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Lapatinib Revenue (Million USD) by Players (2015-2020)
Table 12. Global Lapatinib Revenue Share by Players (2015-2020)
Table 13. Global Lapatinib Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Lapatinib Revenue Market Share by Regions (2015-2020)
Table 15. North America Lapatinib Revenue by Countries (2015-2020)
Table 16. North America Lapatinib Revenue Market Share by Countries (2015-2020)
Table 17. Europe Lapatinib Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Lapatinib Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Lapatinib Revenue by Countries (2015-2020)
Table 20. South America Lapatinib Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Lapatinib Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Lapatinib Revenue Market Share by Countries (2015-2020)
Table 23. Global Lapatinib Revenue (Million USD) by Type (2015-2020)
Table 24. Global Lapatinib Revenue Share by Type (2015-2020)
Table 25. Global Lapatinib Revenue Forecast by Type (2021-2025)
Table 26. Global Lapatinib Revenue by Application (2015-2020)
Table 27. Global Lapatinib Revenue Share by Application (2015-2020)
Table 28. Global Lapatinib Revenue Forecast by Application (2021-2025)
Table 29. Global Lapatinib Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Lapatinib Picture
Figure 2. Global Lapatinib Revenue Market Share by Type in 2019
Figure 3. 250 mg Tablets Picture
Figure 4. Type II Picture
Figure 5. Lapatinib Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Drug store Picture
Figure 8. Global Lapatinib Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Lapatinib Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Lapatinib Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Lapatinib Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Lapatinib Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Lapatinib Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Lapatinib Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Lapatinib Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Lapatinib Revenue Market Share in 2019
Figure 17. Global Top 10 Players Lapatinib Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Lapatinib Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Lapatinib Revenue Market Share by Regions (2015-2020)
Figure 21. Global Lapatinib Revenue Market Share by Regions in 2018
Figure 22. North America Lapatinib Revenue and Growth Rate (2015-2020)
Figure 23. Europe Lapatinib Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Lapatinib Revenue and Growth Rate (2015-2020)
Figure 25. South America Lapatinib Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Lapatinib Revenue and Growth Rate (2015-2020)
Figure 27. North America Lapatinib Revenue Market Share by Countries (2015-2020)
Figure 28. North America Lapatinib Revenue Market Share by Countries in 2019
Figure 29. USA Lapatinib Revenue and Growth Rate (2015-2020)
Figure 30. Canada Lapatinib Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Lapatinib Revenue and Growth Rate (2015-2020)
Figure 32. Europe Lapatinib Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Lapatinib Revenue Market Share by Countries in 2019
Figure 34. Germany Lapatinib Revenue and Growth Rate (2015-2020)
Figure 35. UK Lapatinib Revenue and Growth Rate (2015-2020)
Figure 36. France Lapatinib Revenue and Growth Rate (2015-2020)
Figure 37. Russia Lapatinib Revenue and Growth Rate (2015-2020)
Figure 38. Italy Lapatinib Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Lapatinib Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Lapatinib Revenue Market Share by Countries in 2019
Figure 41. China Lapatinib Revenue and Growth Rate (2015-2020)
Figure 42. Japan Lapatinib Revenue and Growth Rate (2015-2020)
Figure 43. Korea Lapatinib Revenue and Growth Rate (2015-2020)
Figure 44. India Lapatinib Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Lapatinib Revenue and Growth Rate (2015-2020)
Figure 46. South America Lapatinib Revenue Market Share by Countries (2015-2020)
Figure 47. South America Lapatinib Revenue Market Share by Countries in 2019
Figure 48. Brazil Lapatinib Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Lapatinib Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Lapatinib Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Lapatinib Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Lapatinib Revenue and Growth Rate (2015-2020)
Figure 53. UAE Lapatinib Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Lapatinib Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Lapatinib Revenue and Growth Rate (2015-2020)
Figure 56. Global Lapatinib Revenue Share by Type (2015-2020)
Figure 57. Global Lapatinib Revenue Share by Type in 2019
Figure 58. Global Lapatinib Market Share Forecast by Type (2021-2025)
Figure 59. Global 250 mg Tablets Revenue Growth Rate (2015-2020)
Figure 60. Global Type II Revenue Growth Rate (2015-2020)
Figure 61. Global Lapatinib Revenue Share by Application (2015-2020)
Figure 62. Global Lapatinib Revenue Share by Application in 2019
Figure 63. Global Lapatinib Market Share Forecast by Application (2021-2025)
Figure 64. Global Hospital Revenue Growth Rate (2015-2020)
Figure 65. Global Drug store Revenue Growth Rate (2015-2020)
Figure 66. Global Lapatinib Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Lapatinib Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Lapatinib Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Lapatinib Revenue Market Forecast (2021-2025)
Figure 70. Europe Lapatinib Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Lapatinib Revenue Market Forecast (2021-2025)
Figure 72. South America Lapatinib Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Lapatinib Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---